Phase 4 study of additional cilostazol for overcoming biochemical aspirin resistance in the chronic stroke patients.
Phase of Trial: Phase IV
Latest Information Update: 15 Sep 2016
At a glance
- Drugs Cilostazol (Primary)
- Indications Embolism and thrombosis; Stroke
- Focus Pharmacodynamics
- 26 Jan 2010 Actual number of patients (244) added as reported by ClinicalTrials.gov record.
- 26 Jan 2010 Actual end date (1 Jul 2008) added as reported by ClinicalTrials.gov record.
- 26 Jan 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History